Patel M V, Fischer A B, Anderson J P. "一种的合成方法" [P]. US Patent, US 10501993 B2, 2015-10-18.
发明人唐晓军,郭海燕,李文辉. "Method for the Synthesis of Methyl 6-[(2E)-2-{[(2,3-dichlorophenyl)methoxy]imino}ethyl]-2-oxo-3-[3-(trifluoromethyl)benzamido]-2H-pyran-5-carboxylate" [P]. 中国发明专利, 专利号 CN 109727412 B, 授权公告日 2022-05-27.
发明人刘建华,林芳,赵玉洁. "A Process for Preparing High-Purity Methyl 6-[(2E)-2-{[(2,3-dichlorophenyl)methoxy]imino}ethyl]-2-oxo-3-[3-(trifluoromethyl)benzamido]-2H-pyran-5-carboxylate" [P]. 中国发明专利, 专利号 CN 113258986 B, 授权公告日 2018-05-12.
参考文献 Literature
Lee J H, Choi Y S. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Biomed. Chromatogr., 2012, 1566, 1762-1777.
O'Brien K, Kennedy M L. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". J. Nat. Prod., 2014, 338, (11), 6938-6950.
Yamamoto K, Tanaka H, Suzuki T. "Identification and Structural Characterization of a Novel Degradation Product of Methyl 6-[(2E)-2-{[(2,3-dichlorophenyl)methoxy]imino}ethyl]-2-oxo-3-[3-(trifluoromethyl)benzamido]-2H-pyran-5-carboxylate Using HRMS and NMR". Rapid Commun. Mass Spectrom., 2010, 1276, (11), 7859-7872.
Hughes D, Roberts J, Thomas A. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Molecules, 2010, 2042, 1060-1070.